1. Home
  2. VATE vs QTRX Comparison

VATE vs QTRX Comparison

Compare VATE & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo INNOVATE Corp.

VATE

INNOVATE Corp.

HOLD

Current Price

$15.28

Market Cap

168.2M

Sector

Industrials

ML Signal

HOLD

Logo Quanterix Corporation

QTRX

Quanterix Corporation

HOLD

Current Price

$3.02

Market Cap

160.0M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
VATE
QTRX
Founded
1994
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
168.2M
160.0M
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
VATE
QTRX
Price
$15.28
$3.02
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
$6.00
AVG Volume (30 Days)
55.7K
1.5M
Earning Date
05-14-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,246,000,000.00
$37,632,000.00
Revenue This Year
N/A
$25.49
Revenue Next Year
N/A
$10.04
P/E Ratio
N/A
N/A
Revenue Growth
12.55
64.52
52 Week Low
$3.75
$2.40
52 Week High
$16.71
$8.77

Technical Indicators

Market Signals
Indicator
VATE
QTRX
Relative Strength Index (RSI) 66.82 50.61
Support Level $4.48 $2.95
Resistance Level N/A $3.65
Average True Range (ATR) 1.23 0.24
MACD 0.19 0.07
Stochastic Oscillator 77.92 84.25

Price Performance

Historical Comparison
VATE
QTRX

About VATE INNOVATE Corp.

Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments. Its segments include Infrastructure, Life Sciences and Spectrum, and Other segment. Through its subsidiaries it provides fully integrated structural and steel construction services; supports healthcare and biotechnology product development; and operates Over-The-Air (OTA) broadcasting stations across the United States (U.S.) including Puerto Rico.

About QTRX Quanterix Corporation

Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.

Share on Social Networks: